₹ 683.18 Cr
2.37%
S&P BSE Healthcare TRI
INF209KB1N91
1000.0
1000.0
1000
Dhaval Shah, Dhaval Joshi
Fund Performance | 1Y (%) | 3Y (%) | 5Y (%) |
---|---|---|---|
Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth | 53.3 | 13.77 | - |
S&P BSE Healthcare TRI | 50.08 | 13.58 | 22.23 |
Equity
Debt
Others
The scheme seeks to provides long term capital appreciation by investing in equity/equity related instruments of the companies in the Pharmaceuticals, Healthcare and Allied sectors in India.
Company | Holdings (%) |
---|---|
Sun Pharmaceutical Industries Ltd. | 14.66 |
Cipla Ltd. | 8.9 |
Torrent Pharmaceuticals Ltd. | 7.68 |
Apollo Hospitals Enterprise Ltd. | 6.32 |
Aurobindo Pharma Ltd. | 5.92 |
Fortis Healthcare Ltd. | 5.06 |
Zydus Lifesciences Ltd. | 4.54 |
Ajanta Pharma Ltd. | 4.45 |
Gland Pharma Ltd. | 4.21 |
Lupin Ltd. | 3.8 |
Sector | Holdings (%) |
---|---|
Healthcare | 93.86 |
Others | 2.25 |
Insurance | 1.86 |
Services | 1.03 |
Chemicals | 0.99 |
N/A | 0.01 |
Scheme Name | 5Y (%) |
---|---|
ABSL Pharma and Healthcare Reg Gr | 0.0 |
ICICI Pru Pharma Healthcare and Diagnostics PHD Fund Cum | 27.6 |
Tata India Pharma & Healthcare Reg Gr | 25.17 |
UTI Healthcare Reg Gr | 24.81 |
Nippon India Pharma Fund Gr Gr | 26.37 |
Mirae Asset Healthcare Reg Gr | 27.12 |
LIC MF Healthcare Fund Reg Gr | 20.85 |
SBI HEALTHCARE Opportunities Reg Gr | 26.98 |
DSP Healthcare Reg Gr | 27.95 |
ITI Pharma and Healthcare Fund Reg Gr | 0.0 |